{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T22:06:38Z","timestamp":1791324398931,"version":"4.3.1"},"reference-count":101,"publisher":"American Society for Clinical Investigation","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,3,9]]},"abstract":"<jats:p>Despite the rising incidence of autoimmunity, therapeutic options for patients with autoimmune disease still rely on decades-old immunosuppressive strategies that risk severe and potentially fatal complications. Thus, novel therapeutic approaches for autoimmune diseases are greatly needed in order to minimize treatment-related toxicity. Such strategies would ideally target only the autoreactive immune components to preserve beneficial immunity. Here, we review how several decades of basic, translational, and clinical research on the immunology of pemphigus vulgaris (PV), an autoantibody-mediated skin disease, have enabled the development of targeted immunotherapeutic strategies. We discuss research to elucidate the pathophysiology of PV and how the knowledge afforded by these studies has led to the preclinical and clinical testing of targeted approaches to neutralize autoantibodies, to induce antigen-specific tolerance, and to specifically eliminate autoreactive B cells in PV.<\/jats:p>","DOI":"10.1172\/jci.insight.92021","type":"journal-article","created":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T11:01:03Z","timestamp":1488970863000},"source":"Crossref","is-referenced-by-count":40,"title":["Setting the target for pemphigus vulgaris therapy"],"prefix":"10.1172","volume":"2","author":[{"given":"Christoph T.","family":"Ellebrecht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9389-7918","authenticated-orcid":true,"given":"Aimee S.","family":"Payne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2017,3,9]]},"reference":[{"key":"B1","unstructured":"National Institutes of Health Report of the Director 2012. National Institute of Health. https:\/\/report.nih.gov\/pdf\/NIH_Biennial_Report_2012.pdf Accessed February 10, 2017"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2014.03.020"},{"issue":"7","key":"B3","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1001\/archderm.1976.01630310024005","article-title":"Pemphigus: a 20-year review of 107 patients treated with corticosteroids","volume":"112","author":"Rosenberg","year":"1976","journal-title":"Arch Dermatol"},{"key":"B4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a180","article-title":"Bullous pemphigoid and pemphigus vulgaris--incidence and mortality in the UK: population based cohort study","volume":"337","author":"Langan","year":"2008","journal-title":"BMJ"},{"key":"B5"},{"issue":"2 Pt 1","key":"B6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0190-9622(99)70183-0","article-title":"The clinical phenotype of pemphigus is defined by the anti-desmoglein autoantibody profile","volume":"40","author":"Amagai","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.1999.02752.x"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0625.2010.01069.x"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/exd.13106"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198205203062001"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI115968"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI117349"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M115.668061"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1006\/clin.1997.4408"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1172\/JCI24185"},{"issue":"9","key":"B16","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.4049\/jimmunol.137.9.2835","article-title":"Defining the role of complement in experimental pemphigus vulgaris in mice","volume":"137","author":"Anhalt","year":"1986","journal-title":"J Immunol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11144.x"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(00)00158-4"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1046\/j.0019-2805.2001.01341.x"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-09-179754"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.4.2170"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.181.3.1825"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1172\/JCI64413"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.1999.00463.x"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.339"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10463.x"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0050696"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0602973103"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M110.172874"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI60139"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2013.224"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2006.03.006"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5982"},{"key":"B34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5167","article-title":"Shared VH1-46 gene usage by pemphigus vulgaris autoantibodies indicates common humoral immune responses among patients","volume":"5","author":"Cho","year":"2014","journal-title":"Nat Commun"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1126\/science.1071559"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1606272113"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.170.1.635"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.6.3883"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2012.46"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.19.7658"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1126\/science.2894075"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.88.11.5056"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0039.1994.tb02390.x"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12337585"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.92.25.11935"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.172.10.6468"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2010.330"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(96)80066-1"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.01.012"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.04.039"},{"issue":"8","key":"B51","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1001\/archderm.139.8.1051","article-title":"Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases","volume":"139","author":"Ahmed","year":"2003","journal-title":"Arch Dermatol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70004-2"},{"issue":"2","key":"B53","doi-asserted-by":"crossref","first-page":"150","DOI":"10.2340\/0001555575150152","article-title":"The steroid-sparing effect of long-term plasmapheresis in pemphigus","volume":"75","author":"S\u00f8ndergaard","year":"1995","journal-title":"Acta Derm Venereol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.109297"},{"issue":"175","key":"B55","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005166","article-title":"Long-term remissions of severe pemphigus after rituximab therapy are associated with prolonged failure of desmoglein B cell response","volume":"5","author":"Colliou","year":"2013","journal-title":"Sci Transl Med"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062930"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.178"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.172"},{"issue":"9","key":"B59","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1001\/archdermatol.2012.1522","article-title":"Adjuvant rituximab therapy of pemphigus: a single-center experience with 31 patients","volume":"148","author":"Lunardon","year":"2012","journal-title":"Arch Dermatol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1586\/eci.11.22"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1186\/ar3337"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/art.21617"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2011.448"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2014.291"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M808813200"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1111\/exd.12355"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1111\/1523-1747.ep12317587"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5701132"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1159\/000367682"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1038\/nri2153"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700790"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/nri2206"},{"issue":"188","key":"B73","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006168","article-title":"Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis","volume":"5","author":"Lutterotti","year":"2013","journal-title":"Sci Transl Med"},{"issue":"1","key":"B74","article-title":"An open-label phase I clinical study to assess the safety of PI-0824 in patients with pemphigus vulgaris","volume":"125","author":"Werth","year":"2005","journal-title":"J Invest Dermatol"},{"key":"B75","article-title":"Venom immunotherapy for preventing allergic reactions to insect stings","volume":"10","author":"Boyle","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2008.01.072"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.12.1080"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1172\/JCI82771"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.014209"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2133.2000.03328.x"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1021\/bi961985t"},{"issue":"Pt 3","key":"B82","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1042\/bj20031731","article-title":"Elucidation of eukaryotic elongation factor-2 contact sites within the catalytic domain of Pseudomonas aeruginosa exotoxin A","volume":"379","author":"Yates","year":"2004","journal-title":"Biochem J"},{"issue":"Pt 4","key":"B83","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1242\/jcs.112.4.467","article-title":"The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum","volume":"112","author":"Jackson","year":"1999","journal-title":"J Cell Sci"},{"key":"B84","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1146\/annurev.bi.61.070192.001555","article-title":"Recombinant toxins as novel therapeutic agents","volume":"61","author":"Pastan","year":"1992","journal-title":"Annu Rev Biochem"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1126\/science.aaf6756"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.86.24.10024"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1172\/JCI46110"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2009.83"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407222"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.3008226"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)61403-3"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.56.2025"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-04-348540"},{"key":"B94","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1103849"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3838"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.41"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1038\/nature03843"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000002053"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-16-0040"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00840.x"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1016\/j.csbj.2016.09.003"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/92021\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T13:51:35Z","timestamp":1779198695000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/92021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3,9]]},"references-count":101,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2017,3,9]]},"published-print":{"date-parts":[[2017,3,9]]}},"alternative-id":["10.1172\/jci.insight.92021"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.92021","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,3,9]]},"article-number":"e92021"}}